Standard
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective. / Deacon, Carolyn F; Holst, Jens J.
In:
Biochemical and Biophysical Research Communications, Vol. 294, No. 1, 2002, p. 1-4.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Deacon, CF & Holst, JJ 2002, '
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.',
Biochemical and Biophysical Research Communications, vol. 294, no. 1, pp. 1-4.
https://doi.org/10.1016/S0006-291X(02)00359-5
APA
Deacon, C. F., & Holst, J. J. (2002).
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective. Biochemical and Biophysical Research Communications,
294(1), 1-4.
https://doi.org/10.1016/S0006-291X(02)00359-5
Vancouver
Deacon CF, Holst JJ.
Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective. Biochemical and Biophysical Research Communications. 2002;294(1):1-4.
https://doi.org/10.1016/S0006-291X(02)00359-5
Author
Deacon, Carolyn F ; Holst, Jens J. / Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective. In: Biochemical and Biophysical Research Communications. 2002 ; Vol. 294, No. 1. pp. 1-4.
Bibtex
@article{85e56350ab4c11ddb5e9000ea68e967b,
title = "Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.",
abstract = "Udgivelsesdato: 2002-May-31",
author = "Deacon, {Carolyn F} and Holst, {Jens J}",
note = "Keywords: Antigens, CD26; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; History, 20th Century; History, 21st Century; Peptide Fragments; Protease Inhibitors; Protein Precursors",
year = "2002",
doi = "10.1016/S0006-291X(02)00359-5",
language = "English",
volume = "294",
pages = "1--4",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier",
number = "1",
}
RIS
TY - JOUR
T1 - Dipeptidyl peptidase IV inhibition as an approach to the treatment and prevention of type 2 diabetes: a historical perspective.
AU - Deacon, Carolyn F
AU - Holst, Jens J
N1 - Keywords: Antigens, CD26; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; History, 20th Century; History, 21st Century; Peptide Fragments; Protease Inhibitors; Protein Precursors
PY - 2002
Y1 - 2002
N2 - Udgivelsesdato: 2002-May-31
AB - Udgivelsesdato: 2002-May-31
U2 - 10.1016/S0006-291X(02)00359-5
DO - 10.1016/S0006-291X(02)00359-5
M3 - Journal article
C2 - 12054731
VL - 294
SP - 1
EP - 4
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
SN - 0006-291X
IS - 1
ER -
